Cargando…

Mining Disaggregase Sequence Space to Safely Counter TDP-43, FUS, and α-Synuclein Proteotoxicity

Hsp104 is an AAA+ protein disaggregase, which can be potentiated via diverse mutations in its autoregulatory middle domain (MD) to mitigate toxic misfolding of TDP-43, FUS, and α-synuclein implicated in fatal neurodegenerative disorders. Problematically, potentiated MD variants can exhibit off-targe...

Descripción completa

Detalles Bibliográficos
Autores principales: Tariq, Amber, Lin, JiaBei, Jackrel, Meredith E., Hesketh, Christina D., Carman, Peter J., Mack, Korrie L., Weitzman, Rachel, Gambogi, Craig, Murillo, Oscar A. Hernandez, Sweeny, Elizabeth A., Gurpinar, Esin, Yokom, Adam L., Gates, Stephanie N., Yee, Keolamau, Sudesh, Saurabh, Stillman, Jacob, Rizo, Alexandra N., Southworth, Daniel R., Shorter, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6750954/
https://www.ncbi.nlm.nih.gov/pubmed/31433984
http://dx.doi.org/10.1016/j.celrep.2019.07.069
_version_ 1783452546023555072
author Tariq, Amber
Lin, JiaBei
Jackrel, Meredith E.
Hesketh, Christina D.
Carman, Peter J.
Mack, Korrie L.
Weitzman, Rachel
Gambogi, Craig
Murillo, Oscar A. Hernandez
Sweeny, Elizabeth A.
Gurpinar, Esin
Yokom, Adam L.
Gates, Stephanie N.
Yee, Keolamau
Sudesh, Saurabh
Stillman, Jacob
Rizo, Alexandra N.
Southworth, Daniel R.
Shorter, James
author_facet Tariq, Amber
Lin, JiaBei
Jackrel, Meredith E.
Hesketh, Christina D.
Carman, Peter J.
Mack, Korrie L.
Weitzman, Rachel
Gambogi, Craig
Murillo, Oscar A. Hernandez
Sweeny, Elizabeth A.
Gurpinar, Esin
Yokom, Adam L.
Gates, Stephanie N.
Yee, Keolamau
Sudesh, Saurabh
Stillman, Jacob
Rizo, Alexandra N.
Southworth, Daniel R.
Shorter, James
author_sort Tariq, Amber
collection PubMed
description Hsp104 is an AAA+ protein disaggregase, which can be potentiated via diverse mutations in its autoregulatory middle domain (MD) to mitigate toxic misfolding of TDP-43, FUS, and α-synuclein implicated in fatal neurodegenerative disorders. Problematically, potentiated MD variants can exhibit off-target toxicity. Here, we mine disaggregase sequence space to safely enhance Hsp104 activity via single mutations in nucleotide-binding domain 1 (NBD1) or NBD2. Like MD variants, NBD variants counter TDP-43, FUS, and α-synuclein toxicity and exhibit elevated ATPase and disaggregase activity. Unlike MD variants, non-toxic NBD1 and NBD2 variants emerge that rescue TDP-43, FUS, and α-synuclein toxicity. Potentiating substitutions alter NBD1 residues that contact ATP, ATP-binding residues, or the MD. Mutating the NBD2 protomer interface can also safely ameliorate Hsp104. Thus, we disambiguate allosteric regulation of Hsp104 by several tunable structural contacts, which can be engineered to spawn enhanced therapeutic disaggregases with minimal off-target toxicity.
format Online
Article
Text
id pubmed-6750954
institution National Center for Biotechnology Information
language English
publishDate 2019
record_format MEDLINE/PubMed
spelling pubmed-67509542019-09-18 Mining Disaggregase Sequence Space to Safely Counter TDP-43, FUS, and α-Synuclein Proteotoxicity Tariq, Amber Lin, JiaBei Jackrel, Meredith E. Hesketh, Christina D. Carman, Peter J. Mack, Korrie L. Weitzman, Rachel Gambogi, Craig Murillo, Oscar A. Hernandez Sweeny, Elizabeth A. Gurpinar, Esin Yokom, Adam L. Gates, Stephanie N. Yee, Keolamau Sudesh, Saurabh Stillman, Jacob Rizo, Alexandra N. Southworth, Daniel R. Shorter, James Cell Rep Article Hsp104 is an AAA+ protein disaggregase, which can be potentiated via diverse mutations in its autoregulatory middle domain (MD) to mitigate toxic misfolding of TDP-43, FUS, and α-synuclein implicated in fatal neurodegenerative disorders. Problematically, potentiated MD variants can exhibit off-target toxicity. Here, we mine disaggregase sequence space to safely enhance Hsp104 activity via single mutations in nucleotide-binding domain 1 (NBD1) or NBD2. Like MD variants, NBD variants counter TDP-43, FUS, and α-synuclein toxicity and exhibit elevated ATPase and disaggregase activity. Unlike MD variants, non-toxic NBD1 and NBD2 variants emerge that rescue TDP-43, FUS, and α-synuclein toxicity. Potentiating substitutions alter NBD1 residues that contact ATP, ATP-binding residues, or the MD. Mutating the NBD2 protomer interface can also safely ameliorate Hsp104. Thus, we disambiguate allosteric regulation of Hsp104 by several tunable structural contacts, which can be engineered to spawn enhanced therapeutic disaggregases with minimal off-target toxicity. 2019-08-20 /pmc/articles/PMC6750954/ /pubmed/31433984 http://dx.doi.org/10.1016/j.celrep.2019.07.069 Text en This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Tariq, Amber
Lin, JiaBei
Jackrel, Meredith E.
Hesketh, Christina D.
Carman, Peter J.
Mack, Korrie L.
Weitzman, Rachel
Gambogi, Craig
Murillo, Oscar A. Hernandez
Sweeny, Elizabeth A.
Gurpinar, Esin
Yokom, Adam L.
Gates, Stephanie N.
Yee, Keolamau
Sudesh, Saurabh
Stillman, Jacob
Rizo, Alexandra N.
Southworth, Daniel R.
Shorter, James
Mining Disaggregase Sequence Space to Safely Counter TDP-43, FUS, and α-Synuclein Proteotoxicity
title Mining Disaggregase Sequence Space to Safely Counter TDP-43, FUS, and α-Synuclein Proteotoxicity
title_full Mining Disaggregase Sequence Space to Safely Counter TDP-43, FUS, and α-Synuclein Proteotoxicity
title_fullStr Mining Disaggregase Sequence Space to Safely Counter TDP-43, FUS, and α-Synuclein Proteotoxicity
title_full_unstemmed Mining Disaggregase Sequence Space to Safely Counter TDP-43, FUS, and α-Synuclein Proteotoxicity
title_short Mining Disaggregase Sequence Space to Safely Counter TDP-43, FUS, and α-Synuclein Proteotoxicity
title_sort mining disaggregase sequence space to safely counter tdp-43, fus, and α-synuclein proteotoxicity
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6750954/
https://www.ncbi.nlm.nih.gov/pubmed/31433984
http://dx.doi.org/10.1016/j.celrep.2019.07.069
work_keys_str_mv AT tariqamber miningdisaggregasesequencespacetosafelycountertdp43fusandasynucleinproteotoxicity
AT linjiabei miningdisaggregasesequencespacetosafelycountertdp43fusandasynucleinproteotoxicity
AT jackrelmeredithe miningdisaggregasesequencespacetosafelycountertdp43fusandasynucleinproteotoxicity
AT heskethchristinad miningdisaggregasesequencespacetosafelycountertdp43fusandasynucleinproteotoxicity
AT carmanpeterj miningdisaggregasesequencespacetosafelycountertdp43fusandasynucleinproteotoxicity
AT mackkorriel miningdisaggregasesequencespacetosafelycountertdp43fusandasynucleinproteotoxicity
AT weitzmanrachel miningdisaggregasesequencespacetosafelycountertdp43fusandasynucleinproteotoxicity
AT gambogicraig miningdisaggregasesequencespacetosafelycountertdp43fusandasynucleinproteotoxicity
AT murillooscarahernandez miningdisaggregasesequencespacetosafelycountertdp43fusandasynucleinproteotoxicity
AT sweenyelizabetha miningdisaggregasesequencespacetosafelycountertdp43fusandasynucleinproteotoxicity
AT gurpinaresin miningdisaggregasesequencespacetosafelycountertdp43fusandasynucleinproteotoxicity
AT yokomadaml miningdisaggregasesequencespacetosafelycountertdp43fusandasynucleinproteotoxicity
AT gatesstephanien miningdisaggregasesequencespacetosafelycountertdp43fusandasynucleinproteotoxicity
AT yeekeolamau miningdisaggregasesequencespacetosafelycountertdp43fusandasynucleinproteotoxicity
AT sudeshsaurabh miningdisaggregasesequencespacetosafelycountertdp43fusandasynucleinproteotoxicity
AT stillmanjacob miningdisaggregasesequencespacetosafelycountertdp43fusandasynucleinproteotoxicity
AT rizoalexandran miningdisaggregasesequencespacetosafelycountertdp43fusandasynucleinproteotoxicity
AT southworthdanielr miningdisaggregasesequencespacetosafelycountertdp43fusandasynucleinproteotoxicity
AT shorterjames miningdisaggregasesequencespacetosafelycountertdp43fusandasynucleinproteotoxicity